Integrative Genomic Analyses Identify as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma

English version České info

Background:
Traditionally, non-small cell lung cancer is treated as a single disease entity in terms of systemic therapy. Emerging evidence suggests the major subtypes—adenocarcinoma (AC) and squamous cell carcinoma (SqCC)—respond differently to therapy. Identification of the molecular differences between these tumor types will have a significant impact in designing novel therapies that can improve the treatment outcome.

Methods and Findings:
We used an integrative genomics approach, combing high-resolution comparative genomic hybridization and gene expression microarray profiles, to compare AC and SqCC tumors in order to uncover alterations at the DNA level, with corresponding gene transcription changes, which are selected for during development of lung cancer subtypes. Through the analysis of multiple independent cohorts of clinical tumor samples (>330), normal lung tissues and bronchial epithelial cells obtained by bronchial brushing in smokers without lung cancer, we identified the overexpression of BRF2, a gene on Chromosome 8p12, which is specific for development of SqCC of lung. Genetic activation of BRF2, which encodes a RNA polymerase III (Pol III) transcription initiation factor, was found to be associated with increased expression of small nuclear RNAs (snRNAs) that are involved in processes essential for cell growth, such as RNA splicing. Ectopic expression of BRF2 in human bronchial epithelial cells induced a transformed phenotype and demonstrates downstream oncogenic effects, whereas RNA interference (RNAi)-mediated knockdown suppressed growth and colony formation of SqCC cells overexpressing BRF2, but not AC cells. Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.

Conclusions:
This is the first study, to our knowledge, to show that the focal amplification of a gene in Chromosome 8p12, plays a key role in squamous cell lineage specificity of the disease. Our data suggest that genetic activation of BRF2 represents a unique mechanism of SqCC lung tumorigenesis through the increase of Pol III-mediated transcription. It can serve as a marker for lung SqCC and may provide a novel target for therapy.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Integrative Genomic Analyses Identify as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma. PLoS Med 7(7): e32767. doi:10.1371/journal.pmed.1000315
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000315

Souhrn

Zdroje

1. ParkinDM

BrayF

FerlayJ

PisaniP

2005

Global cancer statistics, 2002.

CA Cancer J Clin

108

2. JemalA

SiegelR

WardE

HaoY

XuJ

2008

Cancer statistics, 2008.

CA Cancer J Clin

3. MurrayCJ

LopezAD

1997

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study.

Lancet

349

1498

1504

4. TravisWD

2002

Pathology of lung cancer.

Clin Chest Med

81, viii

5. KimHS

ParkK

JunHJ

YiSY

LeeJ

2009

Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras.

Oncology

239

246

6. ScagliottiG

HannaN

FossellaF

SugarmanK

BlatterJ

2009

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.

Oncologist

253

263

7. GarrawayLA

SellersWR

2006

Lineage dependency and lineage-survival oncogenes in human cancer.

Nat Rev Cancer

593

602

8. GiangrecoA

GrootKR

JanesSM

2007

Lung cancer and lung stem cells: strange bedfellows?

Am J Respir Crit Care Med

175

547

553

9. FisherGH

WellenSL

KlimstraD

LenczowskiJM

TichelaarJW

2001

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Genes Dev

3249

3262

10. GuerraC

MijimolleN

DhawahirA

DubusP

BarradasM

2003

Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.

Cancer Cell

111

120

11. MeuwissenR

LinnSC

van der ValkM

MooiWJ

BernsA

2001

Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.

Oncogene

6551

6558

12. JohnsonL

MercerK

GreenbaumD

BronsonRT

CrowleyD

2001

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.

Nature

410

1111

1116

13. GarrawayLA

WeirBA

ZhaoX

WidlundH

BeroukhimR

2005

“Lineage addiction” in human cancer: lessons from integrated genomics.

Cold Spring Harb Symp Quant Biol

14. AlbertsonDG

2006

Gene amplification in cancer.

Trends Genet

447

455

15. LockwoodWW

ChariR

CoeBP

GirardL

MacaulayC

2008

DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers.

Oncogene

4615

4624

16. KendallJ

LiuQ

BaklehA

KrasnitzA

NguyenKC

2007

Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.

Proc Natl Acad Sci U S A

104

16663

16668

17. TononG

WongKK

MaulikG

BrennanC

FengB

2005

High-resolution genomic profiles of human lung cancer.

Proc Natl Acad Sci U S A

102

9625

9630

18. GarnisC

DaviesJJ

BuysTP

TsaoMS

MacAulayC

2005

Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression.

Oncogene

4806

4812

19. LockwoodWW

CoeBP

WilliamsAC

MacAulayC

LamWL

2007

Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines.

Int J Cancer

120

436

443

20. BaldwinC

GarnisC

ZhangL

RosinMP

LamWL

2005

Multiple microalterations detected at high frequency in oral cancer.

Cancer Res

7561

7567

21. CoeBP

LockwoodWW

GirardL

ChariR

MacaulayC

2006

Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer.

Br J Cancer

1927

1935

22. IshkanianAS

MalloffCA

WatsonSK

DeLeeuwRJ

ChiB

2004

A tiling resolution DNA microarray with complete coverage of the human genome.

Nat Genet

299

303

23. WatsonSK

deLeeuwRJ

HorsmanDE

SquireJA

LamWL

2007

Cytogenetically balanced translocations are associated with focal copy number alterations.

Hum Genet

120

795

805

24. KhojastehM

LamWL

WardRK

MacAulayC

2005

A stepwise framework for the normalization of array CGH data.

BMC Bioinformatics

274

25. ChiB

DeLeeuwRJ

CoeBP

MacAulayC

LamWL

2004

SeeGH–a software tool for visualization of whole genome array comparative genomic hybridization data.

BMC Bioinformatics

26. ChiB

deLeeuwRJ

CoeBP

NgRT

MacAulayC

2008

MD-SeeGH: a platform for integrative analysis of multi-dimensional genomic data.

BMC Bioinformatics

243

27. JongK

MarchioriE

MeijerG

VaartAV

YlstraB

2004

Breakpoint identification and smoothing of array comparative genomic hybridization data.

Bioinformatics

3636

3637

28. BildAH

YaoG

ChangJT

WangQ

PottiA

2006

Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Nature

439

353

357

29. ChariR

LonerganKM

NgRT

MacAulayC

LamWL

2007

Effect of active smoking on the human bronchial epithelium transcriptome.

BMC Genomics

297

30. RamirezRD

SheridanS

GirardL

SatoM

KimY

2004

Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.

Cancer Res

9027

9034

31. SatoM

VaughanMB

GirardL

PeytonM

LeeW

2006

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

Cancer Res

2116

2128

32. SambrookJ

RussellDW

2001

Molecular cloning: a laboratory manual

New York

Cold Spring Harbor Laboratory Press

33. TusherVG

TibshiraniR

ChuG

2001

Significance analysis of microarrays applied to the ionizing radiation response.

Proc Natl Acad Sci U S A

5116

5121

34. LukC

TsaoMS

BayaniJ

ShepherdF

SquireJA

2001

Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.

Cancer Genet Cytogenet

125

35. SySM

WongN

LeeTW

TseG

MokTS

2004

Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.

Eur J Cancer

1082

1094

36. CroceCM

2008

Oncogenes and cancer.

N Engl J Med

358

502

511

37. ZhaoX

WeirBA

LaFramboiseT

LinM

BeroukhimR

2005

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.

Cancer Res

5561

5570

38. SchrammL

PendergrastPS

SunY

HernandezN

2000

Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.

Genes Dev

2650

2663

39. CabartP

MurphyS

2001

BRFU, a TFIIB-like factor, is directly recruited to the TATA-box of polymerase III small nuclear RNA gene promoters through its interaction with TATA-binding protein.

J Biol Chem

276

43056

43064

40. WhiteRJ

2004

RNA polymerase III transcription and cancer.

Oncogene

3208

3216

41. WhiteRJ

2005

RNA polymerases I and III, growth control and cancer.

Nat Rev Mol Cell Biol

42. GoodfellowSJ

WhiteRJ

2007

Regulation of RNA polymerase III transcription during mammalian cell growth.

Cell Cycle

2323

2326

43. WoiwodeA

JohnsonSA

ZhongS

ZhangC

RoederRG

2008

PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex.

Mol Cell Biol

4204

4214

44. Felton-EdkinsZA

KennethNS

BrownTR

DalyNL

Gomez-RomanN

2003

Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc.

Cell Cycle

181

184

45. Gomez-RomanN

Felton-EdkinsZA

KennethNS

GoodfellowSJ

AthineosD

2006

Activation by c-Myc of transcription by RNA polymerases I, II and III.

Biochem Soc Symp

141

154

46. MarshallL

KennethNS

WhiteRJ

2008

Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation.

Cell

133

47. JohnsonSA

DubeauL

JohnsonDL

2008

Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

J Biol Chem

283

19184

19191

48. SchrammL

HernandezN

2002

Recruitment of RNA polymerase III to its target promoters.

Genes Dev

2593

2620

49. SaxenaA

MaB

SchrammL

HernandezN

2005

Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription.

Mol Cell Biol

9406

9418

50. DieciG

FiorinoG

CastelnuovoM

TeichmannM

PaganoA

2007

The expanding RNA polymerase III transcriptome.

Trends Genet

614

622

51. CabarcasS

JacobJ

VerasI

SchrammL

2008

Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.

BMC Mol Biol

52. WistubaII

GazdarAF

2006

Lung cancer preneoplasia.

Annu Rev Pathol

331

348

53. SatoM

ShamesDS

GazdarAF

MinnaJD

2007

A translational view of the molecular pathogenesis of lung cancer.

J Thorac Oncol

327

343

54. RewDA

2003

Small RNAs: a new class of genome regulators and their significance.

Eur J Surg Oncol

764

765

55. ButcherSE

BrowDA

2005

Towards understanding the catalytic core structure of the spliceosome.

Biochem Soc Trans

447

449

56. FaustinoNA

CooperTA

2003

Pre-mRNA splicing and human disease.

Genes Dev

419

437

57. HenryRW

MittalV

MaB

KobayashiR

HernandezN

1998

SNAP19 mediates the assembly of a functional core promoter complex (SNAPc) shared by RNA polymerases II and III.

Genes Dev

2664

2672

58. KweiKA

KimYH

GirardL

KaoJ

Pacyna-GengelbachM

2008

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.

Oncogene

3635

3640

59. TanakaH

YanagisawaK

ShinjoK

TaguchiA

MaenoK

2007

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.

Cancer Res

6007

6011

60. WeirBA

WooMS

GetzG

PernerS

DingL

2007

Characterizing the cancer genome in lung adenocarcinoma.

Nature

450

893

898

61. PernerS

WagnerPL

SoltermannA

LaFargueC

TischlerV

2009

TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

J Pathol

217

62. HerbstRS

HeymachJV

LippmanSM

2008

Lung cancer.

N Engl J Med

359

1367

1380

63. BassAJ

2009

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Nat Genet

1238

1242

Štítky

Interné lekárstvo

Článek Estimating the Number of Paediatric Fevers Associated with Malaria Infection Presenting to Africa's Public Health Sector in 2007

Článek HIV in Maternal and Child Heath: Concurrent Crises Demand Cooperation

Článek HIV Testing for Children in Resource-Limited Settings: What Are We Waiting For?

Článek Improving Implementation: Building Research Capacity in Maternal, Neonatal, and Child Health in Africa

Článek Evidence-Based Priority Setting for Health Care and Research: Tools to Support Policy in Maternal, Neonatal, and Child Health in Africa

Článek Three Adult Cases of Meningitis in Vietnam

Článek Association of Early Repolarization Pattern on ECG with Risk of Cardiac and All-Cause Mortality: A Population-Based Prospective Cohort Study (MONICA/KORA)

Článek Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya

Článek A Model for the Roll-Out of Comprehensive Adult Male Circumcision Services in African Low-Income Settings of High HIV Incidence: The ANRS 12126 Bophelo Pele Project

Článek Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review

Článek A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

Článek Financing Maternal and Child Health—What Are the Limitations in Estimating Donor Flows and Resource Needs?

Článek Improving Prevention of Mother-to-Child Transmission of HIV Care and Related Services in Eastern Rwanda

Článek Social Relationships and Mortality Risk: A Meta-analytic Review

Článok vyšiel v časopise

PLOS Medicine

2010 Číslo 7

Najčítanejšie tento týždeň

Najčítanejšie v tomto čísle

Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz

nový kurz

Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy